Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Can Xu

Showing results (331-340 of 361) with videos related to

Pageof 37
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|November 29, 2016
Converting Red Blood Cells to Efficient Microreactors for Blood DetoxificationCan Xu, Xiangyu Yang, Xiao Fu, et al.
Surgical Endoscopy|June 28, 2022
Ultrasound-guided quadratus lumborum block provided more effective analgesia for children undergoing lower abdominal laparoscopic surgery: a randomized clinical trialYue Zhang, Yan-Ping Wang, Hai-Tao Wang, et al.
Neuro-Oncology|June 6, 2023
EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMTLei Xin, Yanli Tan, Yuanxue Zhu, et al.
ACS Applied Materials & Interfaces|September 30, 2017
Nonuniform Composition Profiles in Amorphous Multimetal Oxide Thin Films Deposited from Aqueous SolutionKeenan N Woods, Milana C Thomas, Gavin Mitchson, et al.
Nucleic Acids Research|December 17, 2025
Amplification-free cancer diagnosis based on inhibition of Cas12a activity by site-specific 5mC-modified cfDNAFeng Yang, Can Xu, Chunhong Li, et al.
Bioorganic Chemistry|July 14, 2023
Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activityKun Liu, Min Mo, Gang Yu, et al.
Frontiers in Oncology|May 16, 2022
lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted TherapyCan Xu, Jixing Zhao, Jia Song, et al.
Cell Reports. Medicine|January 5, 2023
Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseasesJiawei Guo, Fuxiao Wang, Yan Hu, et al.
Journal of Cellular and Molecular Medicine|February 5, 2016
Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expressionLijuan Zhao, Shuman Li, Lin Gan, et al.
Journal of Crohn'S & Colitis|January 14, 2022
The Development and Validation of Anti-paratuberculosis-nocardia Polypeptide Antibody [Anti-pTNP] for the Diagnosis of Crohn's DiseaseHan Gao, Qiong He, Chunjin Xu, et al.
Pageof 37

Showing results (331-340 of 361) with videos related to

Sort By:
Pageof 37
Advanced Materials (Deerfield Beach, Fla.)|November 29, 2016
Converting Red Blood Cells to Efficient Microreactors for Blood DetoxificationCan Xu, Xiangyu Yang, Xiao Fu, et al.
Surgical Endoscopy|June 28, 2022
Ultrasound-guided quadratus lumborum block provided more effective analgesia for children undergoing lower abdominal laparoscopic surgery: a randomized clinical trialYue Zhang, Yan-Ping Wang, Hai-Tao Wang, et al.
Neuro-Oncology|June 6, 2023
EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMTLei Xin, Yanli Tan, Yuanxue Zhu, et al.
ACS Applied Materials & Interfaces|September 30, 2017
Nonuniform Composition Profiles in Amorphous Multimetal Oxide Thin Films Deposited from Aqueous SolutionKeenan N Woods, Milana C Thomas, Gavin Mitchson, et al.
Nucleic Acids Research|December 17, 2025
Amplification-free cancer diagnosis based on inhibition of Cas12a activity by site-specific 5mC-modified cfDNAFeng Yang, Can Xu, Chunhong Li, et al.
Bioorganic Chemistry|July 14, 2023
Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activityKun Liu, Min Mo, Gang Yu, et al.
Frontiers in Oncology|May 16, 2022
lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted TherapyCan Xu, Jixing Zhao, Jia Song, et al.
Cell Reports. Medicine|January 5, 2023
Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseasesJiawei Guo, Fuxiao Wang, Yan Hu, et al.
Journal of Cellular and Molecular Medicine|February 5, 2016
Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expressionLijuan Zhao, Shuman Li, Lin Gan, et al.
Journal of Crohn'S & Colitis|January 14, 2022
The Development and Validation of Anti-paratuberculosis-nocardia Polypeptide Antibody [Anti-pTNP] for the Diagnosis of Crohn's DiseaseHan Gao, Qiong He, Chunjin Xu, et al.
Pageof 37